Cita APA (7a ed.)

Hussain, M., Tejeda, G. S., & Baillie, G. S. (2025). Posttranslational modifications of phosphodiesterase type 4 enzymes represent novel points for therapeutic targeting. Wiley. https://doi.org/10.1111/febs.70205

Cita Chicago Style (17a ed.)

Hussain, Madihah, Gonzalo S. Tejeda, y George S. Baillie. Posttranslational Modifications of Phosphodiesterase Type 4 Enzymes Represent Novel Points for Therapeutic Targeting. Wiley, 2025. https://doi.org/10.1111/febs.70205.

Cita MLA (9a ed.)

Hussain, Madihah, et al. Posttranslational Modifications of Phosphodiesterase Type 4 Enzymes Represent Novel Points for Therapeutic Targeting. Wiley, 2025. https://doi.org/10.1111/febs.70205.